UnknownNCT03339258
A Randomized Controlled Trial of Doxazosin for Nightmares, Sleep Disturbance, and Non-Nightmare Clinical Symptoms in PTSD
Medication studyAges 18–75United States
Understand this study
Who could participate?
Listed age limits: 18 years to 75 years.
- Listed locations
- San FranciscoSee all locations and recruitment
- Study phase
- Phase 2Usually explores whether the intervention may work, while continuing to monitor safety.
What to know before participating
A point to clarify
This summary does not cover all risks or eligibility requirements. What risks or changes to my care would apply to me?
Things to check before joining
Study start dateStarted: April 15, 2018
- Recruitment status
- Unknown
- Enrollment listed in the registry
- 80
- Sponsor
- San Francisco Veterans Affairs Medical Center
- Sponsor type
- Hospital / academic medical center
- Study type
- Drug
- Intervention type
- Drug
- Study phase
- Phase 2Usually explores whether the intervention may work, while continuing to monitor safety.
- Locations
- United States
- Age range
- From 18 Years to 75 Years
- Official registry ID
- NCT03339258
- Official title
Show the full official title
A Randomized, Double-Blind, Placebo-Controlled Trial of Doxazosin for Nightmares, Sleep Disturbance, and Non-Nightmare Clinical Symptoms in Post-Traumatic Stress
Recruitment & locations
Status unknownThis badge reflects the study status reported by the registry. Check the registry for the latest information.
San Francisco
Interested in joining this study?
Questions about this study
Who is behind this study?
The study sponsor is San Francisco Veterans Affairs Medical Center, a hospital or academic medical center.
Does this study involve medication?
Yes. The study involves medication, including Doxazosin Mesylate, Extended Release and Placebo.
Who can participate?
Listed age limits: 18 years to 75 years.
